Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bovine collagen oligopeptide refers to short-chain peptides derived from the enzymatic hydrolysis of type I and III collagens sourced from the hide, bones, or tendons of cows. These oligopeptides are highly bioavailable and are commonly used as dietary supplements in powder, capsule, or liquid form. They provide essential amino acids such as glycine and proline that support the synthesis of new collagen in human tissues. Bovine collagen oligopeptides are primarily used to promote skin elasticity and hydration, support joint health (including osteoarthritis), improve bone strength (osteoporosis), enhance muscle mass recovery after exercise, and may aid gut health. The mechanism of action is believed to involve providing building blocks for connective tissue repair and stimulating fibroblast activity for new extracellular matrix formation[1][2][3][4][5]. Bovine-derived collagens are considered generally recognized as safe by regulatory authorities when consumed appropriately[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bovine collagen oligopeptide.